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Skeletal muscle released significant amounts of alpha amino nitrogen after an overnight fast. Most individual amino acids were released. Alanine output was by far the greatest. The pattern of release probably reflects both the composition of muscle protein undergoing degradation and de novo synthesis of alanine by transamination. A significant correlation was observed between the extent of release of each amino acid and its ambient arterial concentration.
Elevation of forearm insulin in eight subjects from postabsorptive (12 uU/ml) to high physiologic levels (157 /IU/ml) in addition to stimulating muscle glucose uptake blocked muscle alpha amino nitrogen release by 74%. Consistent declines in output were seen for leucine, isoleucine, tyrosine, phenylalanine, threonine, glycine, and a-aminobutyric acid. Alanine output was insignificantly affected. Doubling forearm insulin levels (from 10 to 20 iAU/ml) in eight subjects increased muscle glucose uptake in three and blocked alpha amino nitrogen output in two although both effects were seen concurrently in only one subject. Changes in net amino acid balance after insulin could be accounted for by increased transport of amino acids into muscle cells or retardation of their exit.
It is likely that ambient arterial amino acid concentrations are established and maintained primarily by the extent of muscle amino acid release. The individual amino acids whose outputs from forearm muscle decline after forearm insulinization correspond well with those whose levels fall systematically after systemic insulinization. This suggests that declines in amino acid levels after systemic insulinization are due to inhibition of muscle release. Doubling basal insulin approaches the threshold both for blockade of muscle amino acid output and stimulation of glucose uptake, effects which appear to occur independently.
INTRODUCTION
Skeletal muscle in man, by virtue of its large mass and high protein content, is a major depot for amino acids both in free and peptide-bound form. It might be anticipated that factors altering muscle amino acid extraction from plasma or release into it would profoundly influence plasma levels.
That muscle releases amino acids postabsorptively has been inferred from the progressive rise in plasma amino acids seen in eviscerated animals (3) (4) (5) (6) . A striking reduction in this rise upon insulin administration implicated muscle as a site for the action of this hormone on amino acid metabolism. The enhanced accumulation of methionine-&'S in muscle protein after insulin supported this concept (7) . More recent studies utilizing rat diaphragm (8) (9) (10) and perfused heart preparations (11) clearly show that insulin promotes movement of amino acids into striated muscle. Insulin also increases amino acid uptake by adipose tissue (12, 13) .
To relate these animal studies to intact postabsorptive man, amino acid balance across skeletal muscle and
The Journal of Clinical Investigation Volume 48 1969 across subcutaneous adipose tissue and skin of the forearmi has been quantified. Changes after the infusion of insulin at two dose levels, directed into the brachial artery, have also been examined. In addition to describing hormonal effects on amino acid balance across peripheral tissues under physiologic conditions, these studies provide information on how insulin may regulate the flow of amino acids to liver where they can serve as glucose precursors.
METHODS
After an overnight fast, sixteen studies were performed between 8 a.m. and 1 p.m. in 14 normal male volunteers aged 22-45 yr. A polyethylene catheter was passed several centimeters into a large antecubital vein toward the wrist. Care was taken to thread the catheter as deeply as possible assuring that the venous effluent drained deep forearm tissue, mainly muscle. A superficial forearm vein, whose course could easily be seen just beneath the skin, was also catheterized. Blood collected from it drained predominantly subcutaneous adipose tissue and skin. The brachial artery was entered in the antecubital fossa and a polyethylene catheter was threaded through the arterial needle, which pointed proximally, to extend 5 mm beyond the needle tip thereby creating a second inner lumen. Evans' blue dye (T-1824) was infused continuously through the outer lumen, and forearm blood (and plasma) flow was measured by the continuous infusion dye-dilution technique (14) . Solutions were delivered to the brachial artery through a 38 inch length of polyethylene tubing from a 20 ml disposable plastic syringe. Blood samples were collected in heparinized syringes from the artery proximal to the point of dye and subsequent insulin infusion by using the inner lumen. Simultaneously, blood was drawn from the two veins. Care was taken to avoid introducing heparin into the subject. A sphygmomanometer cuff placed about the wrist was inflated above arterial pressure for 5 min before and during each blood collection and during insulin infusion to exclude the hand from study. Forearm volume was determined between the wrist cuff and humeral epicondyles by water displacement. Three metabolic sets, each consisting of an arterial, a deep, and a superficial venous blood sample, were collected at approximately 15 min intervals during a control period. Whole blood glucose was determined in triplicate by the ferricyanide method of Hoffman (Technicon AutoAnalyzer) from portions of these samples added to oxalate-fluoride tubes (15) . Plasma, separated immediately by centrifugation at 40C, was analyzed in duplicate for alpha amino nitrogen (AAN) and free fatty acids (FFA) (16, 17) . A portion was precipitated with 20% sulfosalicylic acid and the protein-free supernatant fluid stored at -20'C. Subsequently, individual amino acids were measured in a single representative arterial and deep venous set using a Beckman model -120C (Beckman Instruments, Inc., Palo Alto, Calif.) amino acid analyzer (18) (glutamine, glutamic acid, asparagine, and aspartic acid are not accurately determined by this method). Serum from nonheparinized blood was analyzed for immunoreactive insulin (IRI) by a modification (19) (25) . Adipose tissue, on the other hand, is at most 2% protein (26) . Of the 22 simultaneous arterial and deep venous serum IRI determinations in these 16 studies, the arterial level was greater than the venous level in 12, equal in 5, and less than venous in 5. Resting forearm plasma flow averaged 2.2 ±0.22 (SEM) ml/min per 100 ml forearm.
In six of the eight subjects subsequently to receive the "high" dose insulin infusion, arterio-deep venous differences for 20 individual amino acids were determined in one set of base line samples (Fig. 1 ). Significant outputs were demonstrable for practically all with alanine making the single greatest contribution to resting amino acid release. Serine and citrulline were unusual in that neither an output nor an uptake was regularly seen. Cystine was the only amino acid consistently taken up by forearm muscle in the postabsorptive state. For each of the six subjects, large amino acid outputs were associated with high arterial levels. This relationship between amino acid A-DV and arterial level is illustrated for each subject in Fig. 2 . Plasma flow need not be considered in constructing such a correlation for a particu-ALA lar subject since it is the same for each amino acid. the changes were not statistically significant. Except in two subjects at the 90 min period, flow determinations in each study after the 26 min interval deviated less than 25% from the average for that entire study, After the insulin infusion, glucose A-DV and A-SV rose to a maximum of 25.1 and 10.6 mg/100 ml, respectively. FFA release from subcutaneous adipose tissue was inhibited completely as A-SV rose from -0.14 to +0.04 mEq/liter at 90 min. The increase in A-DV for FFA from +0.04 to +0.14 mEq/liter, while possibly representing increased muscle FFA extraction, more probably reflects blockade of FFA release from lipocytes located between muscle fibers in the deep system (21, 24) .
GLY
At the 60 min interval, when flow had returned essentially to base line, net AAN release from muscle had declined 74% as the A-DV, which was initally -0.57 mmole/liter, reached -0.15 mmole/liter. Insulin blocked amino acid release from muscle in all eight subjects. The magnitude of change in arteriovenous difference depended on the basal value (Fig. 3) . Significant net amino acid uptake after insulin infusion was not seen; consequently, when the basal arteriovenous difference was only slightly negative, the insulin response was small. Superficial tissues appeared to behave qualitatively like muscle. When a sizable negative resting A-SV was present, it declined; and consequently, insulin-induced changes were large (Fig. 3) . However, -negligible resting A-SV's in three subjects were unaffected by insulin precluding demonstration of a significant blockade of release from superficial tissues for the group as a whole (Table II) 
* Probability that the change in A-DV after insulin is a chance occurrence (paired t test).
A ±SEM.
interval in one.2 In Table III these values are compared to preinsulin values for the same subjects. Consistent declines in muscle release of threonine, glycine, aaminobutyric acid, isoleucine, leucine, tyrosine, and phenylalanine were seen after insulin. Release of other amino acids decreased as well but these changes were more variable. It is noteworthy that alanine, which makes the greatest contribution to basal output, was little affected. Its release decreased approximately 17%, a change which was not significant. As indicated, arterial levels were unchanged since only forearm muscle, a small portion of total body muscle mass, was exposed to elevated insulin levels. Insulin could produce the observed changes by increasing the movement of amino acids into muscle or by decreasing their exit. Both actions are known to occur in in vitro systems (10, 29) . In the present investigation changes in net amino acid balance, the algebraic sum of these two processes, have been described. The relative importance of stimulation of entry as against inhibition of exit is not determinable.
Response to a small increment in insulin. In eight subjects insulin was delivered into the brachial artery 'For technical reasons insufficient blood was obtained at 60 min in one subject to permit measurement of individual amino acids. His peak response for AAN occurred at 45 min. at 10 /AU/min per kg body weight for 26 min, one-tenth the infusion rate used to achieve maximal physiologic insulinization. Serum IRI was measured in deep venous blood at 15 and 20 min in addition to the intervals previously used and doubled during the infusion (Table IV) . Systemic (arterial) IRI did not rise significantly.
Among these subjects, the changes from control in metabolite arteriovenous differences at the 26 min interval must be interpreted conservatively because mean plasma flow increased significantly during the infusion from 1.9 to 2.8 ml/min per 100 ml forearm. After 26 min, however, plasma flow declined and did not differ from control levels. Each flow determination in all studies after the infusion was completed deviated by less than 25% from the mean for that study except in one subject at the 90 min interval.
Doubling basal insulin levels did not affect extraction of glucose by superficial tissues (A-SV). However, a slight rise in muscle glucose extraction occurred which was significant at 45 min. With regard to FFA release by superficial tissues, an antilipolytic effect was observed. Though release of adipose tissue FFA was incompletely blocked, a change of 0.17 mEq/liter (-0.27 to -0.10 mEq/liter) after a small increment in insulin equaled the change of 0.18 mEqAiter (-0.14 to +0.04 mEq/liter, insulin levels. The difference between the two groups lies mainly in the greater basal lipolysis among subjects who received the "low" dose infusion. As a group there were no changes in AAN arteriovenous difference across deep or superficial tissues when basal insulin levels were doubled except for A-DV at 26 min, a change attributable mainly to increased plasma flow. It is apparent from an examination of individual responses to the "low" dose insulin infusion (Table V) that the mean increase in muscle extraction of glucose at 45 min was attributable to a definite response of subjects B, 0, and Ri. AAN responses (excluding the 26 min interval) were evident in subjects B and D. Thus, while B responded with changes in A-DV of both glucose and amino acids, an action of insulin on movement of one metabolite without the other occurred in O D, and Ri.
Insulin loss in preparation and delivery. In preparing the insulin infusion and delivering it into the brachial artery, one can anticipate loss of hormone from binding to glassware and plastic tubing (30) . For the "low" dose studies this consideration is of special importance because of the small quantities of insulin involved. To assess these losses the stock insulin solution was assayed directly after dilution in borate buffer (pH 8.0) containing 5% bovine serum albumin. It contained 42.2 U/ml of immunoassayable insulin. In each subject on the day of study and after completion of the insulin infusion, 0.1 ml of the infusate was delivered through the same tubing into the appropriate albumin containing buffer; it was then diluted and assayed. IRI levels in the solution actually delivered to the subject could then be compared with those anticipated had there been no in- sulin loss in preparation and delivery. Insulin losses in the "high" dose study were negligible. An average of only 37% of the calculated dose actually reached the brachial artery in the "low" dose studies (Table VI) .
Disparities in the literature regarding the sensitivity of forearm tissues to small increments in insulin (31, 32) can probably be attributed to differences in insulin loss as we shall discuss later. DISCUSSION In the present investigation amino acid balance across peripheral tissues of man has been measured directly, and alterations induced by elevating insulin within the physiologic range have been defined. After an overnight fast, skeletal muscle is in negative nitrogen balance. Subcutaneous adipose tissue and skin also release AAN, though relative to skeletal muscle the negative arteriovenous difference across superficial tissues is much smaller. The basal pattern of individual amino acids released from forearm muscle that we have observed agrees remarkably well with that described previously by London, Foley, and Webb (33) . The high postabsorptive output of alanine relative to the other amino acids is striking since analysis of a wide variety of specific muscle proteins shows that alanine comprises no more than 10% of these proteins (34) . Even after a 3-6 wk fast when the outputs of most amino acids including alanine have decreased, alanine release remains disproportionately high (35) . Alanine is probably synthesized de novo in substantial amounts by transamination of pyruvate. This process, as well as the composition of muscle protein undergoing breakdown, contributes to the pattern of release.
By using the values for basal forearm plasma flow (F) and AAN arterio-deep venous difference (A-V) measured in the present study (Table I) and applying the Fick expression Q = F(A-V), one can compute the quantity, Q, of amino acids released. This amounts to 1.07 smoles/min per 100 g of forearm muscle (see Appendix). For a man weighing 70 kg whose skeletal muscle comprises 40% of body weight, 0.43 moles/day would be released from this tissue. This estimate agrees well with the total quantity of amino acids consumed by the liver as calculated from direct measurements of both hepatic urea output (36) and amino acid uptake (37) in postabsorptive man. Moreover, agreement is good between the pattern of individual amino acids released by muscle and their pattern of uptake by the liver (37, 38) . If stoichiometrically converted by liver, these amino acids would generate approximately 40 g of glucose. Postaborptive hepatic glucose output is between 150 and 400 g/day (36, (39) (40) (41) . Thus, amino acids delivered from the periphery play a quantitatively minor role as a source of glucose in the early postab-sorptive period. Figures for urinary nitrogen excretion under these conditions support the contention that no more than 25% of the glucose released by liver derives from protein breakdown (42) (43) (44) .
It has been known for a number of years that systemic insulinization, either by glucose or insulin infusion, lowers plasma levels of some amino acids while others are unaffected (45) . Declines in threonine, isoleucine, leucine, tyrosine, phenylalanine, and valine are most consistently seen (46) (47) (48) (49) . Such changes, under the conditions studied, cannot be attributed to hormone effects on a specific tissue nor do they reflect conclusively a direct action of insulin. Changes in systemic insulin and glucose levels evoke compensatory changes in growth hormone, epinephrine, glucagon, and adrenal corticoids, all of which may alter nitrogen metabolism (50) . In the present study, by close intraarterial infusion of insulin, forearm IRI was raised to postprandial levels in the absence of changes in systemic metabolite or IRI concentrations sufficient to evoke hormonal counterregulation. Insulin largely blocked the net output of amino acids from muscle, and probably from adipose tissue and skin as well. While most amino acids appeared to contribute to the 74% decline in total AAN output from muscle, consistent declines were seen only for threonine, isoleucine, leucine, tyrosine, phenylalanine, glycine, and a-aminobutyric acid. The close correspondence between those amino acids known to decrease systemically after systemic insulinization and those whose outputs from forearm muscle dropped after local insulinization in the present study suggest that systemic effects result from an action of insulin on muscle, and further, that factors controlling muscle amino acid release play a primary role in establishing and maintaining plasma levels. Supporting this is our observation that postabsorptive basal outputs of the various amino acids correlate well with ambient arterial levels. In our studies a net accumulation of amino acids in peripheral tissues was not observed even with maximum insulinization. Presumably, it is the combined effects of postprandial elevation of plasma amino acids coupled with the pancreatic insulin release which they stimulate (51) that lead to positive amino acid balance in peripheral tissues. Studies to test this hypothesis are in progress.
The failure of insulin to affect alanine release from forearm muscle along with the known resistance of plasma alanine level to change after systemic insulin administration deserve special comment. Evidence from direct measurements of splanchnic alanine extraction in man (37, 38) and from studies of its conversion to glucose in the perfused liver system (52) suggest that alanine is quantitatively the major nitrogenous glucose precursor.
The absence of an insulin effect on alanine release in the present studies makes it unlikely that regulation of the supply of this amino acid substrate from muscle contributes substantially to insulin's overall antigluconeogenic action. Alanine is also released by the kidney in postabsorptive man (53) . Quantitatively, however, this amounts to less than 25% of that released from muscle.
In our "low" dose insulin studies, blockade of FFA release from forearm adipose tissue when basal insulin levels were doubled confirms previous in vivo (31) and in vitro (54) work demonstrating extreme sensitivity of human adipocytes to insulin. Glucose arteriovenous difference across muscle increased in several subjects, and in others an increase could not be demonstrated, indicating that a doubling of basal insulin concentration approaches the threshold value for this biologic effect of insulin. Langs and Andres reported a small but reproducible increase in muscle glucose uptake when insulin was infused into the brachial artery at the same rate we have used for our "low" dose studies (32) . In contrast,
Zierler and Rabinowitz could demonstrate no change (31) . Insulin readily binds to glassware and plastic tubing (30) accounting for the 63% loss we observed in its preparation and delivery. Slight differences in hormone loss during preparation and delivery could explain the disparities. Glucose uptake of striated muscle incubated in vitro is reproducibly stimulated by the addition of as little insulin as 50 /LU/ml (55) . The threshold of tissue sensitivity to stimulation of amino acid uptake in vitro is about the same (56) . This agrees well with our observation that a doubling of the insulin level blocks net AAN output in some subjects but not in others. That these two actions of insulin, stimulation of glucose uptake and blockade of amino acid release, can occur independent of one another in man is suggested in the present study and has been proved in the in vitro situation. (22, 57) . The assumptions pertaining to the derivation of this factor and their limitations have been previously discussed (22.) The argument hinges on the observations that in lean man muscle comprises 60% of forearm mass while it receives 82% of the blood flow (determined, after epinephrine iontophoresis). In a recent study using the same technique of measuring total forearm flow before and after obliterating superficial flow by epinephrine iontophoresis, it has been found that as much as 50% of resting flow supplies superficial tissue (58) . Additionally, direct measurements of muscle (59) and subcutaneous adipose tissue (60) blood flow using a xenon133 wash-out technique have shown them to be about the same per unit mass (2.5 vs. 2.6 ml/min per 100 g). In view of this recent evidence suggesting, in fact, relative equality of blood flow to the various tissues, QT and QM are probably nearly identical and omission of the correction factor previously used seems reasonable.
APPENDIX

